<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="174729">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00821197</url>
  </required_header>
  <id_info>
    <org_study_id>AT-0910-ST</org_study_id>
    <nct_id>NCT00821197</nct_id>
  </id_info>
  <brief_title>Long-limb or Distal Gastric Bypass for Superobesity - Randomized Study</brief_title>
  <official_title>Long -Limb Gastric or Distal Gastric Bypass in the Treatment of Super Obese Patients - a Prospective Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Aker</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Hospital of Vestfold</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main study objective:

      To evaluate long-limb gastric bypass (150 cm alimentary limb) vs. &quot;distal&quot; gastric bypass
      (common channel 150 cm) in the treatment of superobesity (BMI 50-60 kg/m2).

      The main study hypothesis:

      Distal bypass accomplish an estimated 10-20 % larger weightloss than long-limb gastric
      bypass 1 year after surgery. Patients subject to distal bypass have more gastrointestinal
      side effects and more extensive nutritional deficiences compared to long-limb gastric
      bypass.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Technical data will later be published in detail
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary outcome: weight loss</measure>
    <time_frame>2 (and 5) years postoperatively</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary outcome: Quality of life, nutritional deficiencies, perioperative outcome, change in comorbidity, short and longterm complications, health economic considerations, vitamin and mineral deficiencies</measure>
    <time_frame>2 and 5 years postoperative</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">115</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>long-limb bypass</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Laparoscopic long-limb gastric bypass (150 cm alimentary limb, 50 cm biliopancreatic limb)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Distal gastric bypass</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Laparoscopic distal gastric bypass (150 cm common channel, 50 cm biliopancreatic limb)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>long-limb gastric bypass</intervention_name>
    <description>Laparoscopic long-limb gastric bypass (150 cm alimentary limb, 50 cm biliopancreatic limb)</description>
    <arm_group_label>long-limb bypass</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>distal gastric bypass</intervention_name>
    <description>Laparoscopic distal gastric bypass (150 cm common channel, 50 cm biliopancreatic limb)</description>
    <arm_group_label>Distal gastric bypass</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI 50 - 60 kg/m2 at admission for evaluation for bariatric surgery

          -  BMI 48 - 62 kg/m2 at study inclusion

          -  informed consent

          -  scheduled for bariatric surgery

        Exclusion Criteria:

          -  previous bariatric surgery

          -  previous major abdominal surgery

          -  previous history or established urolithiasis

          -  viral hepatitis, liver cirrhosis of any kind

          -  factors making the patient not eligible to understand and commit to the study
             protocol (severe psychiatric disease or drug/narcotic abuse)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tom Mala MD, PhD Rune Sandbu, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Aker University Hospital / The Hospital of Vestfold</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aker university Hospital, Surgical Dep., The Hospital of Vestfold, Surgical Dep.</name>
      <address>
        <city>Oslo and Tønsberg, Norway</city>
        <state>Oslo/Tønsberg</state>
        <zip>0514/3103</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <link>
    <url>http://www.aus.no/</url>
    <description>hospital site</description>
  </link>
  <link>
    <url>http://www.siv.no</url>
    <description>hospital site</description>
  </link>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 31, 2016</lastchanged_date>
  <firstreceived_date>January 12, 2009</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Tom Mala</investigator_full_name>
    <investigator_title>Tom Mala, surgeon phd/ Rune Sandbu, surgeon phd</investigator_title>
  </responsible_party>
  <keyword>obesity</keyword>
  <keyword>laparoscopy</keyword>
  <keyword>bariatric</keyword>
  <keyword>super obesity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
